Related Experiment Video
Updated: Aug 23, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
The newer fluoroquinolones
Judith A O'Donnell1, Steven P Gelone
1Division of Infectious Diseases, Drexel University, College of Medicine, Medical College of PA Hospital, 3300 Henry Avenue, Philadelphia, PA 19129, USA. jao25@drexel.com
Abstract:
This article discusses the newer fluoroquinolones in detail with respect to their pharmacokinetics, pharmacodynamics, safety, and spectrum of in vitro activity. The newer agents are compared and contrasted with the older ones, particularly ciprofloxacin. Efficacy of the newer fluoroquinolones when compared with antimicrobial agents in other classes is also presented in detail. Appropriate use of the newer fluoroquinolones is addressed, including their ever expanding role in the treatment of both upper and lower respiratory tract infections and skin and soft tissue infection. Available data on the use of the newer fluoroquinolones in the management of genitourinary tract infections, gastrointestinal infections, and osteomyelitis are also discussed.
More Related Videos
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Super-resolution Fluorescence Microscopy
Antimicrobial Effectiveness

